Outpatient prescriptions for the drug increased 71% after the announcement, but the FDA later approved it only for folate deficiency ...

The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate ...

FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.

About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...

After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about ...

Wellcovorin tablets were additionally cleared in the US on Tuesday as the only treatment of cerebral folate deficiency, a ...

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients ...

Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD ...

Six months ago, the federal government loudly proclaimed the likely benefits of an existing drug called leucovorin for ...

The U.S. Food and Drug Administration is considering approval of the drug leucovorin to treat children with cerebral folate deficiency and symptoms of autism. Kevin Pelphrey is the Harrison-Wood ...

The FDA has expanded its approval of leucovorin calcium tablets to treat cerebral folate deficiency in patients with a folate receptor 1 gene variant, according to a press release from the agency.